MedinCell Statistics

Total Valuation

MedinCell has a market cap or net worth of GBP 465.60 million. The enterprise value is 491.90 million.

Market Cap	465.60M
Enterprise Value	491.90M

Important Dates

The last earnings date was Tuesday, June 17, 2025.

Earnings Date	Jun 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	33.07M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	79.46
PS Ratio	20.07
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-31.89
EV / Sales	20.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.12

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	177,064
Profits Per Employee	-117,745
Employee Count	140
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MedinCell has paid 133,850 in taxes.

Income Tax	133,850
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.53% in the last 52 weeks. The beta is 1.08, so MedinCell's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+9.53%
50-Day Moving Average	16.15
200-Day Moving Average	15.70
Relative Strength Index (RSI)	46.65
Average Volume (20 Days)	817

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedinCell had revenue of GBP 23.20 million and -15.42 million in losses.

Revenue	23.20M
Gross Profit	23.20M
Operating Income	-9.00M
Pretax Income	-15.29M
Net Income	-15.42M
EBITDA	-8.26M
EBIT	-9.00M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -38.81% and -66.50%.

Gross Margin	100.00%
Operating Margin	-38.81%
Pretax Margin	-65.92%
Profit Margin	-66.50%
EBITDA Margin	-35.59%
EBIT Margin	-38.81%
FCF Margin	n/a

Dividends & Yields

MedinCell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a